Showing results (351-360 of 426) with videos related to
Sort By:
Pageof 43
Human Antibodies|July 16, 1999
New human fusion partners, ICLU-B, -T, -E for making human hybridomas derived from various immunological cellsH Kawahara, M Maeda-Yamamoto, M Suzuki, et al.Human Antibodies|October 30, 2016
Down-regulation of CYP27B1 gene expression in Iranian patients with relapsing-remitting multiple sclerosisZahra Rezaie, Mohammad Taheri, Leila Kohan, et al.Human Antibodies|October 30, 2016
Single nucleotide polymorphisms in the FOXP3 gene are associated with increased risk of relapsing-remitting multiple sclerosisMohammad Mahdi Eftekharian, Arezou Sayad, Mir Davood Omrani, et al.Human Antibodies|October 30, 2016
Of patents and patent disputes: The TNFα patent files. Part 1: HumiraUlrich StorzHuman Antibodies|December 24, 2016
Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donorsTadesse Bekele Tafesse, Addis Adera Gebru, Semgne Gobalee, et al.Human Antibodies|March 9, 2017
Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitisHernan Nicolas Lemus, Arthur E Warrington, Aleksandar Denic, et al.Human Antibodies|March 9, 2017
Cloning and molecular characterization of the cDNAs encoding the variable regions of an anti-CD20 monoclonal antibodyDariush Shanehbandi, Jafar Majidi, Tohid Kazemi, et al.Human Antibodies|December 3, 2016
The effect of Base Transceiver Station waves on some immunological and hematological factors in exposed personsMohammad Taheri, Ghodratollah Roshanaei, Jamileh Ghaffari, et al.Human Antibodies|October 1, 2016
Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patientsMarzieh Khoshbin Nazdik, Mohammad Taheri, Elham Sajjadi, et al.Pageof 43